Apatinib as Second-line Treatment of Advanced Pancreatic Cancer
Clinical trial NCT02726854 · UNKNOWN
Trial details
- NCT number
- NCT02726854
- Sponsor
- First Affiliated Hospital Xi'an Jiaotong University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-04-01
- Primary completion
- 2017-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.